Tiliroside, a glycosidic flavonoid, inhibits carbohydrate digestion and glucose absorption in the gastrointestinal tract

Molecular Nutrition and Food Research

Volumn 56, Issue 3, 2012, Pages 435-445

  Goto, Tsuyoshi ^a   Horita, Mayuka ^a   Nagai, Hiroyuki ^b   Nagatomo, Akifumi ^c   Nishida, Norihisa ^c   Matsuura, Youichi ^c   Nagaoka, Satoshi ^a  

^a GIFU UNIVERSITY   (Japan)

^b Gifu Prefectural Research Institute for Health and Environmental Science   (Japan)

^c Morishita Jintan Co Ltd   (Japan)

Author keywords

Amylase; Flavonoids; GLUT2; SGLT1; Tiliroside

Indexed keywords

ALPHA AMYLASE PANCREAS ISOENZYME; ANTIDIABETIC AGENT; FLAVONOID; GLUCOSE; GLUCOSE TRANSPORTER 2; PHLORETIN; PHLORIZIN; PLANT EXTRACT; SODIUM GLUCOSE COTRANSPORTER 1; STARCH; TILIROSIDE;

ABSORPTION; ANIMAL; ARTICLE; CELL STRAIN CACO 2; CHEMISTRY; DIGESTION; DRUG ANTAGONISM; DRUG EFFECT; GASTROINTESTINAL TRACT; GLUCOSE TOLERANCE TEST; HUMAN; HYPERINSULINISM; INSTITUTE FOR CANCER RESEARCH MOUSE; INTESTINE CELL; MALE; METABOLISM; MOUSE; PLANT SEED; POSTPRANDIAL STATE; ROSE;

ABSORPTION; ANIMALS; CACO-2 CELLS; DIGESTION; ENTEROCYTES; FLAVONOIDS; GASTROINTESTINAL TRACT; GLUCOSE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 2; HUMANS; HYPERINSULINISM; HYPOGLYCEMIC AGENTS; MALE; MICE; MICE, INBRED ICR; PANCREATIC ALPHA-AMYLASES; PHLORETIN; PHLORHIZIN; PLANT EXTRACTS; POSTPRANDIAL PERIOD; ROSA; SEEDS; SODIUM-GLUCOSE TRANSPORTER 1; STARCH;

MUS;

EID: 84859197004     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100458     Document Type: Article

References (56)

1. Stumvoll, M., Goldstein, B. J., van Haeften, T. W., Type 2 diabetes: pathogenesis and treatment. Lancet 2008, 371, 2153-2156.
2. Zimmet, P., Alberti, K. G., Shaw, J., Global and societal implications of the diabetes epidemic. Nature 2001, 414, 782-787.
3. Ludwig, D. S., The Glycemic Index: Physiological mechanisms relating to obesity. Diabetes and cardiovascular disease. J. Am. Med. Assoc. 2002, 287, 2414-2423.
4. Ceriello, A., Postprandial hyperglycemia and diabetes complications. Diabetes 2005, 54, 1-7.
5. Clissold, S. P., Edwards, C., A preliminary review of its pharmacodynamic and pharmacokinetics properties, and therapeutic potential. Drugs 1998, 35, 214-243.
6. Al Kazaz, M., Desseaux, V., Marchis-Mouren, G., Prodanov, E. et al., The mechanism of porcine pancreatic alpha-amylase. Inhibition of maltopentaose hydrolysis by acarbose, maltose and maltotriose. Eur. J. Biochem. 1998, 252, 100-107.
7. Brown, G. K., Glucose transporters: Structure, function and consequences of deficiency. J. Inherit. Metab. Dis. 2000, 23, 237-246.
8. Kellett, G. L., Brot-Laroche, E., Mace, O. J., Leturque, A., Sugar absorption in the intestine: the role of GLUT2. Annu. Rev. Nutr. 2008, 28, 35-54.
9. Morgan, E. L., Mace, O. J., Affleck, J., Kellett, G. L., Apical GLUT2 and Ca(v)1.3: regulation of rat intestinal glucose and calcium absorption. J. Physiol. 2007, 580, 593-604.
10. Ross, J. A., Kasum, C. M., Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu. Rev. Nutr. 2002, 22, 19-34.
11. Beecher, G. R., Overview of dietary flavonids: Nomenclature, occurrence and intake. J. Nutr. 2003, 133, 3248S-3254S.
12. Arts, I. C., Hollman, P. C., Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 2005, 81, 317S-325S.
13. García-Lafuente, A., Guillamón, E., Villares, A., Rostagno, M. A. et al., Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm. Res. 2009, 58, 537-552.
14. Peluso, M. R., Flavonoids attenuate cardiovascular disease, inhibit phosphodiesterase, and modulate lipid homeostasis in adipose tissue and liver. Exp. Biol. Med. (Maywood) 2006, 231, 1287-1299.
15. Kim, J. S., Kwon, C. S., Son, K. H., Inhibition of alpha-glucosidase and amylase by luteolin, a flavonoid. Biosci. Biotechnol. Biochem. 2000, 64, 2458-2461.
16. Tadera, K., Minami, Y., Takamatsu, K., Matsuoka, T., Inhibition of alpha-glucosidase and alpha-amylase by flavonoids. J. Nutr. Sci. Vitaminol. (Tokyo) 2006, 52, 149-153.
17. Alvarado, F., Hypothesis for the interaction of phloridzin and phloretin with embrane carriers for sugars. Biochim. Biophys. Acta 1967, 135, 483-485.
18. Cermak, R., Landgraf, S., Wolffram, S., Quercetin glucosides inhibit glucose uptake into brush-border-membrane vesicles of porcine jejunum. Br. J. Nutr. 2004, 91, 849-855.
19. Kwon, O., Eck, P., Chen, S. L., Corpe, C. P. et al., Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB J. 2007, 21, 366-377.
20. Matsuda, H., Ninomiya, K., Shimoda, H., Yoshikawa, M., Hepatoprotective principles from the flowers of Tilia argentea (linden): structure requirements of tiliroside and mechanisms of action. Bioorg. Med. Chem. 2002, 10, 707-712.
21. Ninomiya, K., Matsuda, H., Kubo, M., Morikawa, T. et al., Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside. Bioorg. Med. Chem. Lett. 2007, 17, 3059-3064.
22. Tsukamoto, S., Tomise, K., Aburatani, M., Onuki, H. et al., Isolation of cytochrome P450 inhibitors from strawberry fruit, Fragaria ananassa. J. Nat. Prod. 2004, 67, 1839-1841.
23. Goto, T., Teraminami, A., Lee, J. Y., Ohyama, K. et al., Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese-diabetic mice. J. Nutr. Biochem. 2011, In press, DOI: 10.1016/j.jnutbio.2011.04.001.
24. Hanamura, T., Hagiwara, T., Kawagishi, H., Structural and functional characterization of polyphenols isolated from acerola (Malpighia emarginata DC.) fruit. Biosci. Biotechnol. Biochem. 2005, 69, 280-286.
25. Nagaoka, S., Shimizu, K., Kaneko, H., Shibayama, F. et al., A novel protein C-phycocyanin plays a crucial role in the hypocholesterolemic action of Spirulina platensis concentrate in rats. J. Nutr. 2005, 135, 2425-2430.
26. +-D-glucose cotransporter SGLT1 with high affinity. J. Biol. Chem. 2007, 282, 28501-28513.
27. Cornier, M. A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C. et al., The metabolic syndrome. Endocr. Rev. 2008, 29, 777-822.
28. Yach, D., Stuckler, D., Brownell, K. D., Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat. Med. 2006, 12, 62-66.
29. Murase, T., Nagasawa, A., Suzuki, J., Hase, T. et al., Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Int. J. Obes. Relat. Metab. Disord. 2002, 26, 1459-1464.
30. Tsuda, T., Regulation of adipocyte function by anthocyanins; possibility of preventing the metabolic syndrome. J. Agric. Food Chem. 2008, 56, 642-646.
31. Lautt, W. W., Postprandial insulin resistance as an early predictor of cardiovascular risk. Ther. Clin. Risk Manag. 2007, 3, 761-770.
32. Kadowaki, T., Yamauchi, T., Adiponectin and adiponectin receptors. Endocr. Rev. 2005, 26, 439-451.
33. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y. et al., The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 2001, 7, 941-946.
34. Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H. et al., Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 2002, 8, 731-737.
35. Ochiai, H., Ooka, H., Shida, C., Ishikawa, T. et al., Acarbose treatment increases serum total adiponectin levels in patients with type 2 diabetes. Endocr. J. 2008, 55, 549-556.
36. Csaky, T. Z., Fischer, E., Intestinal sugar transport in experimental diabetes. Diabetes 1981, 30, 568-574.
37. Debnam, E. S., Ebrahim, H. Y., Swaine, D. J., Diabetes mellitus and sugar transport across the brush-border and basolateral membranes of rat jejunal enterocytes. J. Physiol. 1990, 424, 13-25.
38. Thomson, A. B., Uptake of glucose into the intestine of diabetic rats: effects of variations in the effective resistance of the unstirred water layer. Diabetes 1981, 30, 247-255.
39. Kellett, G. L., Brot-Laroche, E., Apical GLUT2: A major pathway of intestinal sugar absorption. Diabetes 2005, 54, 3056-3062.
40. Mahraoui, L., Rodolosse, A., Barbat, A., Dussaulx, E. et al., Presence and differential expression of SGLT1, GLUT1, GLUT2, GLUT3 and GLUT5 hexose-transporter mRNAs in Caco-2 cell clones in relation to cell growth and glucose consumption. Biochem. J. 1994, 298, 629-633.
41. Pappenheimer, J. R., On the coupling of membrane digestion with intestinal absorption of sugars and amino acids. Am. J. Physiol. 1993, 265, G409-G417.
42. Ferraris, R. P., Yasharpour, S., Lloyd, K. C., Mirzayan, R. et al., Luminal glucose concentrations in the gut under normal conditions. Am. J. Physiol. 1990, 259, G822-G837.
43. Oike, H., Nagai, K., Fukushima, T., Ishida, N. et al., High-salt diet advances molecular circadian rhythms in mouse peripheral tissues. Biochem. Biophys. Res. Commun. 2010, 402, 7-13.
44. Masumoto, S., Akimoto, Y., Oike, H., Kobori, M., Dietary phloridzin reduces blood glucose levels and reverses Sglt1 expression in the small intestine in streptozotocin-induced diabetic mice. J. Agric. Food Chem. 2009, 57, 4651-4656.
45. Manach, C., Morand, C., Demigné, C., Texier, O. et al., Bioavailability of rutin and quercetin in rats. FEBS Lett. 1997, 409, 12-16.
46. Walle, T., Otake, Y., Walle, U. K., Wilson, F. A., Quercetin glucosides are completely hydrolyzed in ileostomy patients before absorption. J. Nutr. 2000, 130, 2658-2661.
47. Hara, Y., Honda, M., The inhibition of alpha-amylase by tea polophenol. Agric. Biol. Chem. 1990, 54, 1939-1945.
48. Hiratsuka, T., Itoh, N., Seto, H., Dairi, T., Enzymatic properties of futalosine hydrolase, an enzyme essential to a newly identified menaquinone biosynthetic pathway. Biosci. Biotechnol. Biochem. 2009, 73, 1137-1141.
49. Liu, Y. H., Wu, W. C., Lu, Y. L., Lai, Y. J. et al., Antioxidant and amine oxidase inhibitory activities of hydroxyurea. Biosci. Biotechnol. Biochem. 2010, 74, 1256-1260.
50. McDougall, G. J., Stewart, D., The inhibitory effects of berry polyphenols on digestive enzymes. Biofactors 2005, 23, 189-195.
51. Kim, J. H., Ryu, Y. B., Kang, N. S., Lee, B. W. et al., Glycosidase inhibitory flavonoids from Sophora flavescens. Biofactors 2006, 29, 302-305.
52. Paganga, G., Rice-Evans, C. A., The identification of flavonoids as glycosides in human plasma. FEBS Lett. 1997, 401, 78-82.
53. Aziz, A. A., Edwards, C. A., Lean, M. E., Crozier, A., Absorption and excretion of conjugated flavonols, including quercetin-4′-O-beta-glucoside and isorhamnetin-4-O-beta-glucoside by human volunteers after the consumption of onions. Free Radic. Res. 1998, 29, 257-269.
54. Tsuda, T., Horio, F., Osawa, T., Absorption and metabolism of cyanidin 3-O-beta-D-glucoside in rats. FEBS Lett. 1999, 449, 179-182.
55. Calderón-Montaño, J. M., Burgos-Morón, E., Pérez-Guerrero, C., López-Lázaro, M., A review on the dietary flavonoid kaempferol. Mini Rev. Med. Chem. 2011, 11, 298-344.
56. Lo Piparo, E., Scheib, H., Frei, N., Williamson, G. et al., Flavonoids for controlling starch digestion: structural requirements for inhibiting human alpha-amylase. J. Med. Chem. 2008, 51, 3555-3561.